ID

37935

Description

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01292408

Lien

https://clinicaltrials.gov/show/NCT01292408

Mots-clés

Versions (1)
  1. 01/09/2019 01/09/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

1 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT01292408

Anglais

Eligibility Breast Cancer NCT01292408

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with core-biopsy proven invasive adenocarcinoma of the breast
Description

Breast adenocarcinoma Invasive Core needle biopsy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0205281
UMLS CUI [1,3]
C1318309
any tumor with a size ≥ 1cm (not inflammatory breast cancer)
Description

Tumor size | Exception Inflammatory Breast Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0475440
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0278601
who-performance score 0 or 1
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol
Description

Psychological Factors Interfere with Informed Consent | Factor Familial Interferes with Informed Consent | Sociological Factors Interfere with Informed Consent | Geographic Factors Interfere with Informed Consent | Psychological Factors Interfere with Protocol Compliance | Factor Familial Interferes with Protocol Compliance | Sociological Factors Interfere with Protocol Compliance | Geographic Factors Interfere with Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0033898
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0021430
UMLS CUI [2,1]
C1521761
UMLS CUI [2,2]
C0241888
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0021430
UMLS CUI [3,1]
C3850138
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0021430
UMLS CUI [4,1]
C0017444
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0021430
UMLS CUI [5,1]
C0033898
UMLS CUI [5,2]
C0521102
UMLS CUI [5,3]
C0525058
UMLS CUI [6,1]
C1521761
UMLS CUI [6,2]
C0241888
UMLS CUI [6,3]
C0521102
UMLS CUI [6,4]
C0525058
UMLS CUI [7,1]
C3850138
UMLS CUI [7,2]
C0521102
UMLS CUI [7,3]
C0525058
UMLS CUI [8,1]
C0017444
UMLS CUI [8,2]
C0521102
UMLS CUI [8,3]
C0525058
hampered liver or kidney function
Description

Liver Dysfunction | Renal Insufficiency

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
serious gastro-intestinal disease
Description

Gastrointestinal Disease Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0205404
neurological disease (including epilepsy)
Description

Nervous system disorder | Epilepsy

Type de données

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0014544
hematological disease
Description

Hematological Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018939
psoriasis
Description

Psoriasis

Type de données

boolean

Alias
UMLS CUI [1]
C0033860
porphyry
Description

Porphyria

Type de données

boolean

Alias
UMLS CUI [1]
C0032708
g6pd deficiency
Description

Deficiency of glucose-6-phosphate dehydrogenase

Type de données

boolean

Alias
UMLS CUI [1]
C2939465
hypersensitivity for quinine
Description

Quinine allergy

Type de données

boolean

Alias
UMLS CUI [1]
C0571311
use of gold containing drugs, oxyphenbutazone, phenylbutazon, digoxin
Description

Pharmaceutical Preparations Containing Gold | Oxyphenbutazone | Phenylbutazone | Digoxin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0018026
UMLS CUI [2]
C0030078
UMLS CUI [3]
C0031463
UMLS CUI [4]
C0012265
operation for breast cancer foreseen within 14 days after inclusion in the study.
Description

Operative Surgical Procedure Planned Breast Carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1301732
UMLS CUI [1,3]
C0678222
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT01292408

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma Invasive Core needle biopsy
Item
patients with core-biopsy proven invasive adenocarcinoma of the breast
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C1318309 (UMLS CUI [1,3])
Tumor size | Exception Inflammatory Breast Carcinoma
Item
any tumor with a size ≥ 1cm (not inflammatory breast cancer)
boolean
C0475440 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0278601 (UMLS CUI [2,2])
WHO performance status scale
Item
who-performance score 0 or 1
boolean
C1298650 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Psychological Factors Interfere with Informed Consent | Factor Familial Interferes with Informed Consent | Sociological Factors Interfere with Informed Consent | Geographic Factors Interfere with Informed Consent | Psychological Factors Interfere with Protocol Compliance | Factor Familial Interferes with Protocol Compliance | Sociological Factors Interfere with Protocol Compliance | Geographic Factors Interfere with Protocol Compliance
Item
any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol
boolean
C0033898 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C1521761 (UMLS CUI [2,1])
C0241888 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
C3850138 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
C0017444 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
C0033898 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C0525058 (UMLS CUI [5,3])
C1521761 (UMLS CUI [6,1])
C0241888 (UMLS CUI [6,2])
C0521102 (UMLS CUI [6,3])
C0525058 (UMLS CUI [6,4])
C3850138 (UMLS CUI [7,1])
C0521102 (UMLS CUI [7,2])
C0525058 (UMLS CUI [7,3])
C0017444 (UMLS CUI [8,1])
C0521102 (UMLS CUI [8,2])
C0525058 (UMLS CUI [8,3])
Liver Dysfunction | Renal Insufficiency
Item
hampered liver or kidney function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Gastrointestinal Disease Serious
Item
serious gastro-intestinal disease
boolean
C0017178 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Nervous system disorder | Epilepsy
Item
neurological disease (including epilepsy)
boolean
C0027765 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Hematological Disease
Item
hematological disease
boolean
C0018939 (UMLS CUI [1])
Psoriasis
Item
psoriasis
boolean
C0033860 (UMLS CUI [1])
Porphyria
Item
porphyry
boolean
C0032708 (UMLS CUI [1])
Deficiency of glucose-6-phosphate dehydrogenase
Item
g6pd deficiency
boolean
C2939465 (UMLS CUI [1])
Quinine allergy
Item
hypersensitivity for quinine
boolean
C0571311 (UMLS CUI [1])
Pharmaceutical Preparations Containing Gold | Oxyphenbutazone | Phenylbutazone | Digoxin
Item
use of gold containing drugs, oxyphenbutazone, phenylbutazon, digoxin
boolean
C0013227 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0018026 (UMLS CUI [1,3])
C0030078 (UMLS CUI [2])
C0031463 (UMLS CUI [3])
C0012265 (UMLS CUI [4])
Operative Surgical Procedure Planned Breast Carcinoma
Item
operation for breast cancer foreseen within 14 days after inclusion in the study.
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial